Wishpond
Trending >
NEO stock has price target chopped at Paradigm

Following a quarter that he characterized as “lighter than expected”, Paradigm Capital analyst J Marvin Wolff has cut his price target on Neo Performance Materials (Neo Performance Materials Stock Quote, Chart, News, Analysts, Financials TSX:NEO). On March 15, NEO reported... Keep reading

Groupon’s turnaround is accelerating, Roth says
GM stock is a buy, Citi says
HLS has price target cut at Raymond James

STOCK PICKS

More STOCK PICKS →
SYZ stock Sylogist earns target raise at Paradigm

  Its fourth quarter results are out and Paradigm Capital analyst Daniel Rosenberg is feeling more bullish about Sylogist (Sylogist... Read More

PRL stock Propel Holdings wins target raise at Eight Capital

Following the company’s fourth quarter results, Eight Capital analyst Adhir Kadve has raised his price target on Propel Holdings (Propel... Read More

LIFE SCIENCES STOCKS

More LIFE SCIENCES STOCKS →
GUD stock
Feeling GUD: Raymond James raises price target on Knight Therapeutics

Raymond James analyst Rahul Sarugaser is feeling GUD about Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:GUD).... Read More

ATE stock
Antibe Therapeutics placed “Under Review” at Echelon

Bad news for Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:ATE) has Echelon Capital Markets analyst Stefan... Read More

ATE stock
Antibe Therapeutics has more upside still, Paradigm says

The stock has been on a roll, but Paradigm Capital analyst Scott McAuley thinks there is still money to be... Read More

Timely, Pro Stock Picks, In Your Inbox.

AYR Stock AYR stock wins target raise at Beacon

Its fourth quarter results are in the books and Beacon analyst Russell Stanley is even more bullish on AYR Wellness... Read More

VFF stock Village Farms will be the big winner in the cannabis sector, Beacon says

Its fourth quarter results are in the books and Beacon analyst Doug Copper still thinks there is a lot of... Read More

AAWH.U stock Ascend Wellness keeps “Buy” rating at Haywood

Following the company’s fourth quarter results, Haywood Capital Markets analyst Neal Gilmer has maintained his “Buy” rating on Ascend Wellness... Read More

TRENDING STORIES

All TRENDING NEWS →
MOND stock
MOND stock keeps “Buy” rating at Roth

Following the company’s most recent results, Roth MKM analyst Darren Aftahi has maintained his “Buy” rating on Mondee Holdings (Mondee... Read More

NOTE stock
NOTE stock wins target raise at Roth

After a quarter he describes as “fair”, Roth MKM analyst Richard K. Baldry remains bullish on FiscalNote Holdings (FiscalNote Holdings... Read More

BLDP stock
BLDP stock still a pass, Roth says

“Tepid”. That’s how Roth MKM analyst Craig Irwin describes the outlook for Ballard Power (Ballard Power Stock Quote, Chart, News,... Read More

GLXY stock
GLXY earns price target raise at ATB Capital

With Bitcoin flying, ATB Capital Markets analyst Martin Toner has raised his price target on Galaxy Digital Holdings (Galaxy Digital... Read More

NVDA stock
If NVDA sneezes, does the rest of the market catch a cold?

Paradigm Capital Aazan Habib sees signs of a potential for a sector rotation and openly wonders how long the current... Read More

BLN stock
Buy Blackline Safety ahead of Q1 results, ATB says

Ahead of this week’s release of its first quarter results, ATB Capital analyst Martin Toner thinks Blackline Safety (Blackline Safety... Read More

EXE stock
EXE stock wins price target raise at Leede Jones Gable

Its fourth quarter results are in the books and Leede Jones Gable analyst Doug Loe is feeling more bullish about... Read More

DXT stock
dxt
Dexterra Group has price target cut at Beacon

Following fourth quarter results that fell short of his expectations, Beacon Securities analyst Kirk Wilson has chopped his price target... Read More

PROF stock
PROF stock is undervalued, Leede Jones Gable says

Following the company’s fourth quarter results, Leede Jones Gable analyst Doug Loe has maintained his “Buy” rating on Profound Medical... Read More

NLH stock
NLH stock keeps “Buy” rating at Echelon following Q4 results

Its fourth quarter results are in the books and Echelon Capital Markets analyst Stefan Quenneville thinks there is still money... Read More

BRCC stock
BRCC stock is a buy, Roth says

Following the company’s fourth quarter results, Roth MKM analyst George Kelly has maintained his “Buy” rating on BRC (BRC Stock... Read More

AutoCanada
AutoCanada price target cut at National Bank

Following the company’s fourth quarter results, National Bank Financial analyst Maxim Sytchev has cut his price target on AutoCanada (AutoCanada... Read More

Canada Stock Investment Guides

More STOCK GUIDES →

It’s hard to argue with success. All around, 2021 has been pretty outstanding for Canadian stocks,...

So you are a Canadian looking to put some money to work for yourself in the stock market. Or perhaps...

WELL Health